Biosimilars The MasterClass Training 2013

Biosimilars, biobetters and follow-on biologics are considered as one of the fastest growing sectors in the pharmaceutical industry. The challenges that developing and manufacturing companies face are remarkable and the to understand the changing regulatory environment in Europe, USA and in emerging market presents difficulties to the pharmaceutical industry.

KEY TOPICS

Approved Biosimilars in the EU
Pricing and Reimbursement for Biosimilars
Scientific and Development Strategy for a Biosimilar
Biosimilars in the Emerging Markets
The Current legal Environment for Biosimilars
The Future of Biosimilars

This training is especially designed for Members of Board, Vice Presidents, Directors, Heads and Senior Managers involved in: Biologics, Biotechnology &Biogenerics, Biopharmaceuticals & Biotherapeutics, Commercial Affairs, Business Development, Marketing & Sales, Portfolio Planning, Regulatory Compliance, Pricing & Reimburesement, Health Economics, Clinical Immunology, Process Control & Analytical Technologies, Quality Affairs & Quality Control, Analytical Characterisation, Research & Development, Quality Assurance, Scientific Affairs, Commercial Affairs, Pharmacovigilance

This two-day Masterclass
It will cover all the aspects that help pharmaceutical companies to develop Biosimilars, overcome development and manufacturing challenges and understand the regulatory framewrok and the future trends of biosimilar markets.

It will discuss the opportunities presented by the evolving Biosimilars market. The MasterClass is designed to provide representatives of pharmaceutical companies with an overview of Biosimilars.

It is relevant to both innovators facing lifecycle management issues for innovator biologics, and also for those interested in making and licensing biosimilars in the leading highly regulated markets.